Parallel Advisors, LLC Neurocrine Biosciences Inc Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,839 shares of NBIX stock, worth $233,755. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,839

Previous 1,699 8.24%

Holding current value

$233,755

Previous $233,000 9.44%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$114.58 - $153.15 $16,041 - $21,441	140 Added 8.24%	1,839 $211,000
Q2 2024 Aug 08, 2024	BUY	$130.86 - $143.19 $1,570 - $1,718	12 Added 0.71%	1,699 $233,000
Q1 2024 May 06, 2024	BUY	$130.4 - $143.74 $19,690 - $21,704	151 Added 9.83%	1,687 $232,000
Q4 2023 Feb 09, 2024	SELL	$106.07 - $132.76 $32,669 - $40,890	-308 Reduced 16.7%	1,536 $202,000
Q3 2023 May 20, 2024	BUY	$94.02 - $117.1 $67,036 - $83,492	713 Added 63.04%	1,844 $207,000
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $67,036 - $83,492	713 Added 63.04%	1,844 $207,000
Q2 2023 May 20, 2024	BUY	$89.53 - $104.87 $7,878 - $9,228	88 Added 8.44%	1,131 $106,000
Q2 2023 Aug 04, 2023	BUY	$89.53 - $104.87 $7,878 - $9,228	88 Added 8.44%	1,131 $106,000
Q1 2023 May 20, 2024	SELL	$94.11 - $123.02 $60,606 - $79,224	-644 Reduced 38.17%	1,043 $105,000
Q1 2023 Apr 25, 2023	BUY	$94.11 - $123.02 $7,434 - $9,718	79 Added 8.2%	1,043 $105,000
Q4 2022 Feb 03, 2023	BUY	$106.72 - $127.06 $13,126 - $15,628	123 Added 14.63%	964 $115,000
Q3 2022 Nov 10, 2022	BUY	$92.03 - $107.81 $23,559 - $27,599	256 Added 43.76%	841 $89,000
Q2 2022 Aug 01, 2022	SELL	$75.79 - $100.07 $4,092 - $5,403	-54 Reduced 8.45%	585 $57,000
Q1 2022 Apr 28, 2022	BUY	$72.45 - $94.81 $12,678 - $16,591	175 Added 37.72%	639 $59,000
Q4 2021 Jan 20, 2022	BUY	$79.65 - $106.22 $79 - $106	1 Added 0.22%	464 $40,000
Q3 2021 Nov 02, 2021	BUY	$86.18 - $99.03 $22,492 - $25,846	261 Added 129.21%	463 $44,000
Q2 2021 Aug 06, 2021	BUY	$89.43 - $102.27 $2,414 - $2,761	27 Added 15.43%	202 $20,000
Q1 2021 Apr 23, 2021	BUY	$87.57 - $119.4 $262 - $358	3 Added 1.74%	175 $17,000
Q4 2020 Feb 02, 2021	SELL	$86.91 - $108.33 $86 - $108	-1 Reduced 0.58%	172 $16,000
Q3 2020 Oct 27, 2020	BUY	$96.16 - $135.15 $2,788 - $3,919	29 Added 20.14%	173 $17,000
Q2 2020 Jul 16, 2020	SELL	$85.09 - $130.36 $1,616 - $2,476	-19 Reduced 11.66%	144 $17,000
Q1 2020 Apr 27, 2020	BUY	$75.11 - $113.76 $300 - $455	4 Added 2.52%	163 $14,000
Q3 2019 Nov 01, 2019	BUY	$83.82 - $101.5 $2,598 - $3,146	31 Added 24.22%	159 $14,000
Q4 2018 Feb 05, 2019	SELL	$68.32 - $124.36 $409 - $746	-6 Reduced 4.48%	128 $9,000
Q2 2018 Jul 30, 2018	BUY	$75.3 - $105.99 $2,710 - $3,815	36 Added 36.73%	134 $13,000
Q3 2017 Nov 15, 2017	BUY	$47.97 - $61.28 $4,701 - $6,005	98 New	98 $7,000
Q3 2017 Nov 14, 2017	SELL	$47.97 - $61.28 $4,269 - $5,453	-89 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	89	89 $4,000

Others Institutions Holding NBIX

# of Institutions

627

Shares Held

94.3M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Neurocrine Biosciences Inc Transaction History